Abstract
To evaluate the potential of the expression of the sodium/iodide symporter (NIS) as a means of targeting radioiodine to tumor cells, we have employed plasmid-mediated transfection of the NIS gene into a range of mammalian cell hosts. We observed perchlorate-inhibitable iodide uptake up to 41-fold over control in all NIS-transfected cells. We assessed the effect of NIS expression followed by exposure to on the clonogenic survival of UVW glioma cells. After exposure of two-dimensional monolayer cultures of UVW–NIS cells to at a radioactive concentration of 4 MBq/mL, clonogenic survival was reduced to 21%. Similar treatment of UVW–NIS cells in three-dimensional spheroid cultures resulted in a reduction of clonogenic survival to 2.5%. This increase in sensitivity to exposure is likely to be due to a radiological bystander effect. These results are very encouraging for the development of a novel cytotoxic gene-therapy strategy in which a radiological bystander effect plays a significant role in tumor cell sterilization.
| Original language | English |
|---|---|
| Pages (from-to) | 1529-1536 |
| Number of pages | 8 |
| Journal | Cancer Gene Therapy |
| Volume | 7 |
| DOIs | |
| Publication status | Published - 1 Jan 2001 |
Funding
The authors' work is supported by the European Community, The Neuroblastoma Society, the Cancer Research Campaign, the Scottish Hospitals Endowment Trust, and the Dr. Hadwen Trust.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- radiotherapy
- radiopharmaceuticals
- cancer
- NIS
- clonogenicity
- tumor cells
- radiological bystander effect
Fingerprint
Dive into the research topics of 'Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver